|
Market Closed -
London S.E.
12:35:05 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 31.50 GBX | 0.00% |
|
-5.97% | -82.50% |
| 10-19 | Faron Pharmaceuticals Ltd Reports Final Melanoma Survival Data From The MATINS Study At ESMO 2026 | CI |
| 10-08 | Faron Pharmaceuticals Oy - Special Call |
Evolution of the Average Target: Faron Pharmaceuticals Oy
Evolution of the Target Price: Faron Pharmaceuticals Oy
Changes in Analyst Recommendations: Faron Pharmaceuticals Oy
7325bedcb4607b9ceb.Eb-dAJz42KbKnGAIcOQ-NTRZklOYOFBZXY3oHPXXBBw.Q-zkNaTPntKB6wVxPqtPQkwe0znADRw4ZN7YaoeiTXIl2qVOxcuNyJCxUA~1f87e379c97eac4465b084c14cf5a355
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +3,128.51% | |||
| +41.72% | |||||
| +26.36% | |||||
| +10.61% | |||||
| +10.61% | |||||
| +16.9% | |||||
| +37.16% | |||||
| +42.61% | |||||
| -17.48% | |||||
| +30.19% | |||||
| Average | +332.72% | |||||
| Weighted average by Cap. | +23.39% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3762EUR
Average target price
11.66EUR
Spread / Average Target
+3,000.77%
High Price Target
11.66EUR
Spread / Highest target
+3,000.77%
Low Price Target
11.66EUR
Spread / Lowest Target
+3,000.77%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- FARN Stock
- Consensus Faron Pharmaceuticals Oy
Select your edition
All financial news and data tailored to specific country editions
